DOSE-SITE	for a total dose of <RT_DOSE-START> 80.8 Gy <RT_DOSE-END> to <Anatomical_site-START> point A <Anatomical_site-END> is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative
None	for a total dose of <RT_DOSE-START> 80.8 Gy <RT_DOSE-END> to point A is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the <Anatomical_site-START> pelvis <Anatomical_site-END> , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative
None	for a total dose of <RT_DOSE-START> 80.8 Gy <RT_DOSE-END> to point A is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the <Anatomical_site-START> prostate <Anatomical_site-END> that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative
None	for a total dose of <RT_DOSE-START> 80.8 Gy <RT_DOSE-END> to point A is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the <Anatomical_site-START> planning target volume <Anatomical_site-END> ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative
None	for a total dose of <RT_DOSE-START> 80.8 Gy <RT_DOSE-END> to point A is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( <Anatomical_site-START> PTV-1 <Anatomical_site-END> ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative
None	for a total dose of <RT_DOSE-START> 80.8 Gy <RT_DOSE-END> to point A is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a <Anatomical_site-START> boost <Anatomical_site-END> of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative
None	for a total dose of <RT_DOSE-START> 80.8 Gy <RT_DOSE-END> to point A is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total <Anatomical_site-START> boost <Anatomical_site-END> dose of 14.4 Gy to the PTV-2 , for a total cumulative
None	for a total dose of <RT_DOSE-START> 80.8 Gy <RT_DOSE-END> to point A is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the <Anatomical_site-START> PTV-2 <Anatomical_site-END> , for a total cumulative
None	for a total dose of 80.8 Gy to <Anatomical_site-START> point A <Anatomical_site-END> is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of
DOSE-SITE	for a total dose of 80.8 Gy to point A is started 2 months after start of androgen deprivation therapy ( ADT ) , <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the <Anatomical_site-START> pelvis <Anatomical_site-END> , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of
None	for a total dose of 80.8 Gy to point A is started 2 months after start of androgen deprivation therapy ( ADT ) , <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the <Anatomical_site-START> prostate <Anatomical_site-END> that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of
None	for a total dose of 80.8 Gy to point A is started 2 months after start of androgen deprivation therapy ( ADT ) , <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the <Anatomical_site-START> planning target volume <Anatomical_site-END> ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of
None	for a total dose of 80.8 Gy to point A is started 2 months after start of androgen deprivation therapy ( ADT ) , <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( <Anatomical_site-START> PTV-1 <Anatomical_site-END> ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of
None	for a total dose of 80.8 Gy to point A is started 2 months after start of androgen deprivation therapy ( ADT ) , <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a <Anatomical_site-START> boost <Anatomical_site-END> of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of
None	for a total dose of 80.8 Gy to point A is started 2 months after start of androgen deprivation therapy ( ADT ) , <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total <Anatomical_site-START> boost <Anatomical_site-END> dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of
None	for a total dose of 80.8 Gy to point A is started 2 months after start of androgen deprivation therapy ( ADT ) , <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the <Anatomical_site-START> PTV-2 <Anatomical_site-END> , for a total cumulative dose of
None	for a total dose of 80.8 Gy to <Anatomical_site-START> point A <Anatomical_site-END> is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial 44 to <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of
DOSE-SITE	for a total dose of 80.8 Gy to point A is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the <Anatomical_site-START> pelvis <Anatomical_site-END> , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of
None	for a total dose of 80.8 Gy to point A is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the pelvis , then an additional conedown to the <Anatomical_site-START> prostate <Anatomical_site-END> that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of
None	for a total dose of 80.8 Gy to point A is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the <Anatomical_site-START> planning target volume <Anatomical_site-END> ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of
None	for a total dose of 80.8 Gy to point A is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( <Anatomical_site-START> PTV-1 <Anatomical_site-END> ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of
None	for a total dose of 80.8 Gy to point A is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a <Anatomical_site-START> boost <Anatomical_site-END> of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of
None	for a total dose of 80.8 Gy to point A is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total <Anatomical_site-START> boost <Anatomical_site-END> dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of
None	for a total dose of 80.8 Gy to point A is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the <Anatomical_site-START> PTV-2 <Anatomical_site-END> , for a total cumulative dose of
None	of 80.8 Gy to <Anatomical_site-START> point A <Anatomical_site-END> is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8
None	of 80.8 Gy to point A is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the <Anatomical_site-START> pelvis <Anatomical_site-END> , then an additional conedown to the prostate that resulted in a total dose of 65 to <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8
None	of 80.8 Gy to point A is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the <Anatomical_site-START> prostate <Anatomical_site-END> that resulted in a total dose of 65 to <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8
None	of 80.8 Gy to point A is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the <Anatomical_site-START> planning target volume <Anatomical_site-END> ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8
None	of 80.8 Gy to point A is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( <Anatomical_site-START> PTV-1 <Anatomical_site-END> ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8
None	of 80.8 Gy to point A is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a <Anatomical_site-START> boost <Anatomical_site-END> of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8
None	of 80.8 Gy to point A is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total <Anatomical_site-START> boost <Anatomical_site-END> dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8
None	of 80.8 Gy to point A is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the <Anatomical_site-START> PTV-2 <Anatomical_site-END> , for a total cumulative dose of 59.4 Gy 1.8
None	A is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the <Anatomical_site-START> pelvis <Anatomical_site-END> , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x
None	A is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the <Anatomical_site-START> prostate <Anatomical_site-END> that resulted in a total dose of 65 to 70 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x
DOSE-SITE	A is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , total dose of 45 Gy to the <Anatomical_site-START> planning target volume <Anatomical_site-END> ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x
DOSE-SITE	A is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( <Anatomical_site-START> PTV-1 <Anatomical_site-END> ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x
None	A is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a <Anatomical_site-START> boost <Anatomical_site-END> of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x
None	A is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total <Anatomical_site-START> boost <Anatomical_site-END> dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x
None	A is started 2 months after start of androgen deprivation therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the <Anatomical_site-START> PTV-2 <Anatomical_site-END> , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x
None	therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the <Anatomical_site-START> pelvis <Anatomical_site-END> , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy
None	therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the <Anatomical_site-START> prostate <Anatomical_site-END> that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy
DOSE-SITE	therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> to the <Anatomical_site-START> planning target volume <Anatomical_site-END> ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy
DOSE-SITE	therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> to the planning target volume ( <Anatomical_site-START> PTV-1 <Anatomical_site-END> ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy
None	therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> to the planning target volume ( PTV-1 ) ; then a <Anatomical_site-START> boost <Anatomical_site-END> of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy
None	therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total <Anatomical_site-START> boost <Anatomical_site-END> dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy
None	therapy ( ADT ) , 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the <Anatomical_site-START> PTV-2 <Anatomical_site-END> , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy
None	44 to 46 Gy to the <Anatomical_site-START> pelvis <Anatomical_site-END> , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of
None	44 to 46 Gy to the pelvis , then an additional conedown to the <Anatomical_site-START> prostate <Anatomical_site-END> that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of
None	44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the <Anatomical_site-START> planning target volume <Anatomical_site-END> ( PTV-1 ) ; then a boost of <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of
None	44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( <Anatomical_site-START> PTV-1 <Anatomical_site-END> ) ; then a boost of <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of
DOSE-SITE	44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a <Anatomical_site-START> boost <Anatomical_site-END> of <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of
DOSE-SITE	44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 8 fractions , total <Anatomical_site-START> boost <Anatomical_site-END> dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of
DOSE-SITE	44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 8 fractions , total boost dose of 14.4 Gy to the <Anatomical_site-START> PTV-2 <Anatomical_site-END> , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of
None	44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to <Anatomical_site-START> primary target volume <Anatomical_site-END> . Then 5.4 Gy boost to secondary target volume of
None	44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to secondary target volume of
None	44 to 46 Gy to the pelvis , then an additional conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to <Anatomical_site-START> secondary target volume <Anatomical_site-END> of
None	conedown to the <Anatomical_site-START> prostate <Anatomical_site-END> that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of <RT_DOSE-START> 14.4 Gy <RT_DOSE-END> to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven
None	conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the <Anatomical_site-START> planning target volume <Anatomical_site-END> ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of <RT_DOSE-START> 14.4 Gy <RT_DOSE-END> to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven
None	conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( <Anatomical_site-START> PTV-1 <Anatomical_site-END> ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of <RT_DOSE-START> 14.4 Gy <RT_DOSE-END> to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven
DOSE-SITE	conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a <Anatomical_site-START> boost <Anatomical_site-END> of 1.8 Gy fractions x 8 fractions , total boost dose of <RT_DOSE-START> 14.4 Gy <RT_DOSE-END> to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven
DOSE-SITE	conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total <Anatomical_site-START> boost <Anatomical_site-END> dose of <RT_DOSE-START> 14.4 Gy <RT_DOSE-END> to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven
DOSE-SITE	conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of <RT_DOSE-START> 14.4 Gy <RT_DOSE-END> to the <Anatomical_site-START> PTV-2 <Anatomical_site-END> , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven
None	conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of <RT_DOSE-START> 14.4 Gy <RT_DOSE-END> to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to <Anatomical_site-START> primary target volume <Anatomical_site-END> . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven
None	conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of <RT_DOSE-START> 14.4 Gy <RT_DOSE-END> to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven
None	conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of <RT_DOSE-START> 14.4 Gy <RT_DOSE-END> to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to <Anatomical_site-START> secondary target volume <Anatomical_site-END> of 1 - to 1.5-cm margin on all sides , including proven
None	conedown to the prostate that resulted in a total dose of 65 to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of <RT_DOSE-START> 14.4 Gy <RT_DOSE-END> to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of <Anatomical_site-START> 1 - to 1.5-cm margin <Anatomical_site-END> on all sides , including proven
None	to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the <Anatomical_site-START> planning target volume <Anatomical_site-END> ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions .
None	to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( <Anatomical_site-START> PTV-1 <Anatomical_site-END> ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions .
None	to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a <Anatomical_site-START> boost <Anatomical_site-END> of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions .
None	to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total <Anatomical_site-START> boost <Anatomical_site-END> dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions .
None	to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the <Anatomical_site-START> PTV-2 <Anatomical_site-END> , for a total cumulative dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions .
None	to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to <Anatomical_site-START> primary target volume <Anatomical_site-END> . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions .
None	to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions .
None	to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to <Anatomical_site-START> secondary target volume <Anatomical_site-END> of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions .
None	to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of <Anatomical_site-START> 1 - to 1.5-cm margin <Anatomical_site-END> on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions .
None	to 70 Gy 1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven <Anatomical_site-START> nodal involvement <Anatomical_site-END> . Total 50.4 Gy in 28 fractions .
None	1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the <Anatomical_site-START> planning target volume <Anatomical_site-END> ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . 220 cGy twice
None	1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( <Anatomical_site-START> PTV-1 <Anatomical_site-END> ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . 220 cGy twice
None	1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a <Anatomical_site-START> boost <Anatomical_site-END> of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . 220 cGy twice
None	1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total <Anatomical_site-START> boost <Anatomical_site-END> dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . 220 cGy twice
None	1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the <Anatomical_site-START> PTV-2 <Anatomical_site-END> , for a total cumulative dose of 59.4 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . 220 cGy twice
DOSE-SITE	1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy to <Anatomical_site-START> primary target volume <Anatomical_site-END> . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . 220 cGy twice
None	1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . 220 cGy twice
None	1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to <Anatomical_site-START> secondary target volume <Anatomical_site-END> of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . 220 cGy twice
None	1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of <Anatomical_site-START> 1 - to 1.5-cm margin <Anatomical_site-END> on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . 220 cGy twice
None	1.8 Gy fractions x 25 fractions , total dose of 45 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven <Anatomical_site-START> nodal involvement <Anatomical_site-END> . Total 50.4 Gy in 28 fractions . 220 cGy twice
None	Gy to the <Anatomical_site-START> planning target volume <Anatomical_site-END> ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> to primary target volume . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4
None	Gy to the planning target volume ( <Anatomical_site-START> PTV-1 <Anatomical_site-END> ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> to primary target volume . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4
None	Gy to the planning target volume ( PTV-1 ) ; then a <Anatomical_site-START> boost <Anatomical_site-END> of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> to primary target volume . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4
None	Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total <Anatomical_site-START> boost <Anatomical_site-END> dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> to primary target volume . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4
None	Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the <Anatomical_site-START> PTV-2 <Anatomical_site-END> , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> to primary target volume . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4
DOSE-SITE	Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> to <Anatomical_site-START> primary target volume <Anatomical_site-END> . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4
None	Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> to primary target volume . Then 5.4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4
None	Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> to primary target volume . Then 5.4 Gy boost to <Anatomical_site-START> secondary target volume <Anatomical_site-END> of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4
None	Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> to primary target volume . Then 5.4 Gy boost to secondary target volume of <Anatomical_site-START> 1 - to 1.5-cm margin <Anatomical_site-END> on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4
None	Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> to primary target volume . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven <Anatomical_site-START> nodal involvement <Anatomical_site-END> . Total 50.4 Gy in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4
None	; then a <Anatomical_site-START> boost <Anatomical_site-END> of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4 ( total dose : 1320 cGy ) 2
None	; then a boost of 1.8 Gy fractions x 8 fractions , total <Anatomical_site-START> boost <Anatomical_site-END> dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4 ( total dose : 1320 cGy ) 2
None	; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the <Anatomical_site-START> PTV-2 <Anatomical_site-END> , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4 ( total dose : 1320 cGy ) 2
None	; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to <Anatomical_site-START> primary target volume <Anatomical_site-END> . Then <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4 ( total dose : 1320 cGy ) 2
DOSE-SITE	; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> <Anatomical_site-START> boost <Anatomical_site-END> to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4 ( total dose : 1320 cGy ) 2
DOSE-SITE	; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> boost to <Anatomical_site-START> secondary target volume <Anatomical_site-END> of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4 ( total dose : 1320 cGy ) 2
DOSE-SITE	; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> boost to secondary target volume of <Anatomical_site-START> 1 - to 1.5-cm margin <Anatomical_site-END> on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4 ( total dose : 1320 cGy ) 2
DOSE-SITE	; then a boost of 1.8 Gy fractions x 8 fractions , total boost dose of 14.4 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven <Anatomical_site-START> nodal involvement <Anatomical_site-END> . Total 50.4 Gy in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4 ( total dose : 1320 cGy ) 2
None	total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to <Anatomical_site-START> primary target volume <Anatomical_site-END> . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4 ( total dose : 1320 cGy ) 2 Gy fractions x 25 fractions , for a total dose of 50 Gy , to start within 4 hours after the first dose of
None	total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4 ( total dose : 1320 cGy ) 2 Gy fractions x 25 fractions , for a total dose of 50 Gy , to start within 4 hours after the first dose of
None	total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to <Anatomical_site-START> secondary target volume <Anatomical_site-END> of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4 ( total dose : 1320 cGy ) 2 Gy fractions x 25 fractions , for a total dose of 50 Gy , to start within 4 hours after the first dose of
None	total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of <Anatomical_site-START> 1 - to 1.5-cm margin <Anatomical_site-END> on all sides , including proven nodal involvement . Total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4 ( total dose : 1320 cGy ) 2 Gy fractions x 25 fractions , for a total dose of 50 Gy , to start within 4 hours after the first dose of
None	total cumulative dose of 59.4 Gy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven <Anatomical_site-START> nodal involvement <Anatomical_site-END> . Total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4 ( total dose : 1320 cGy ) 2 Gy fractions x 25 fractions , for a total dose of 50 Gy , to start within 4 hours after the first dose of
None	1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to <Anatomical_site-START> primary target volume <Anatomical_site-END> . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . <RT_DOSE-START> 220 cGy <RT_DOSE-END> twice per day in 6 fractions on days - 6 to - 4 ( total dose : 1320 cGy ) 2 Gy fractions x 25 fractions , for a total dose of 50 Gy , to start within 4 hours after the first dose of chemotherapy . 2.8 Gy fractions once
None	1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . <RT_DOSE-START> 220 cGy <RT_DOSE-END> twice per day in 6 fractions on days - 6 to - 4 ( total dose : 1320 cGy ) 2 Gy fractions x 25 fractions , for a total dose of 50 Gy , to start within 4 hours after the first dose of chemotherapy . 2.8 Gy fractions once
None	1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to <Anatomical_site-START> secondary target volume <Anatomical_site-END> of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . <RT_DOSE-START> 220 cGy <RT_DOSE-END> twice per day in 6 fractions on days - 6 to - 4 ( total dose : 1320 cGy ) 2 Gy fractions x 25 fractions , for a total dose of 50 Gy , to start within 4 hours after the first dose of chemotherapy . 2.8 Gy fractions once
None	1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of <Anatomical_site-START> 1 - to 1.5-cm margin <Anatomical_site-END> on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . <RT_DOSE-START> 220 cGy <RT_DOSE-END> twice per day in 6 fractions on days - 6 to - 4 ( total dose : 1320 cGy ) 2 Gy fractions x 25 fractions , for a total dose of 50 Gy , to start within 4 hours after the first dose of chemotherapy . 2.8 Gy fractions once
None	1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy to primary target volume . Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven <Anatomical_site-START> nodal involvement <Anatomical_site-END> . Total 50.4 Gy in 28 fractions . <RT_DOSE-START> 220 cGy <RT_DOSE-END> twice per day in 6 fractions on days - 6 to - 4 ( total dose : 1320 cGy ) 2 Gy fractions x 25 fractions , for a total dose of 50 Gy , to start within 4 hours after the first dose of chemotherapy . 2.8 Gy fractions once
None	Then 5.4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4 ( total dose : <RT_DOSE-START> 1320 cGy <RT_DOSE-END> ) 2 Gy fractions x 25 fractions , for a total dose of 50 Gy , to start within 4 hours after the first dose of chemotherapy . 2.8 Gy fractions once per day x 15 fractions ( total dose : 42 Gy ) over 3 weeks , given between the
None	Then 5.4 Gy boost to <Anatomical_site-START> secondary target volume <Anatomical_site-END> of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4 ( total dose : <RT_DOSE-START> 1320 cGy <RT_DOSE-END> ) 2 Gy fractions x 25 fractions , for a total dose of 50 Gy , to start within 4 hours after the first dose of chemotherapy . 2.8 Gy fractions once per day x 15 fractions ( total dose : 42 Gy ) over 3 weeks , given between the
None	Then 5.4 Gy boost to secondary target volume of <Anatomical_site-START> 1 - to 1.5-cm margin <Anatomical_site-END> on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4 ( total dose : <RT_DOSE-START> 1320 cGy <RT_DOSE-END> ) 2 Gy fractions x 25 fractions , for a total dose of 50 Gy , to start within 4 hours after the first dose of chemotherapy . 2.8 Gy fractions once per day x 15 fractions ( total dose : 42 Gy ) over 3 weeks , given between the
None	Then 5.4 Gy boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven <Anatomical_site-START> nodal involvement <Anatomical_site-END> . Total 50.4 Gy in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4 ( total dose : <RT_DOSE-START> 1320 cGy <RT_DOSE-END> ) 2 Gy fractions x 25 fractions , for a total dose of 50 Gy , to start within 4 hours after the first dose of chemotherapy . 2.8 Gy fractions once per day x 15 fractions ( total dose : 42 Gy ) over 3 weeks , given between the
None	<Anatomical_site-START> boost <Anatomical_site-END> to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4 ( total dose : 1320 cGy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy , to start within 4 hours after the first dose of chemotherapy . 2.8 Gy fractions once per day x 15 fractions ( total dose : 42 Gy ) over 3 weeks , given between the third and fourth chemotherapy
None	boost to <Anatomical_site-START> secondary target volume <Anatomical_site-END> of 1 - to 1.5-cm margin on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4 ( total dose : 1320 cGy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy , to start within 4 hours after the first dose of chemotherapy . 2.8 Gy fractions once per day x 15 fractions ( total dose : 42 Gy ) over 3 weeks , given between the third and fourth chemotherapy
None	boost to secondary target volume of <Anatomical_site-START> 1 - to 1.5-cm margin <Anatomical_site-END> on all sides , including proven nodal involvement . Total 50.4 Gy in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4 ( total dose : 1320 cGy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy , to start within 4 hours after the first dose of chemotherapy . 2.8 Gy fractions once per day x 15 fractions ( total dose : 42 Gy ) over 3 weeks , given between the third and fourth chemotherapy
None	boost to secondary target volume of 1 - to 1.5-cm margin on all sides , including proven <Anatomical_site-START> nodal involvement <Anatomical_site-END> . Total 50.4 Gy in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4 ( total dose : 1320 cGy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy , to start within 4 hours after the first dose of chemotherapy . 2.8 Gy fractions once per day x 15 fractions ( total dose : 42 Gy ) over 3 weeks , given between the third and fourth chemotherapy
None	all sides , including proven <Anatomical_site-START> nodal involvement <Anatomical_site-END> . Total 50.4 Gy in 28 fractions . 220 cGy twice per day in 6 fractions on days - 6 to - 4 ( total dose : 1320 cGy ) 2 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> , to start within 4 hours after the first dose of chemotherapy . 2.8 Gy fractions once per day x 15 fractions ( total dose : 42 Gy ) over 3 weeks , given between the third and fourth chemotherapy courses 2 Gy fractions x 30 fractions ( total of 60
None	dose of 50.4 Gy 1.8 to 2 Gy fractions ( total dose : 68.4 Gy ) 2.5 Gy fractions , five fractions per week 200 cGy twice per day in 6 fractions on days - 6 to - 4 with lung shielding at 10 Gy ( total dose : <RT_DOSE-START> 1200 cGy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 80.4 Gy for <Anatomical_site-START> oropharynx <Anatomical_site-END> ; 75.6 Gy for hypopharynx ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) ,
None	dose of 50.4 Gy 1.8 to 2 Gy fractions ( total dose : 68.4 Gy ) 2.5 Gy fractions , five fractions per week 200 cGy twice per day in 6 fractions on days - 6 to - 4 with lung shielding at 10 Gy ( total dose : <RT_DOSE-START> 1200 cGy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 80.4 Gy for oropharynx ; 75.6 Gy for <Anatomical_site-START> hypopharynx <Anatomical_site-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) ,
None	1.8 to 2 Gy fractions ( total dose : 68.4 Gy ) 2.5 Gy fractions , five fractions per week 200 cGy twice per day in 6 fractions on days - 6 to - 4 with lung shielding at 10 Gy ( total dose : 1200 cGy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 80.4 Gy for <Anatomical_site-START> oropharynx <Anatomical_site-END> ; 75.6 Gy for hypopharynx ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per
None	1.8 to 2 Gy fractions ( total dose : 68.4 Gy ) 2.5 Gy fractions , five fractions per week 200 cGy twice per day in 6 fractions on days - 6 to - 4 with lung shielding at 10 Gy ( total dose : 1200 cGy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 80.4 Gy for oropharynx ; 75.6 Gy for <Anatomical_site-START> hypopharynx <Anatomical_site-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per
DOSE-SITE	68.4 Gy ) 2.5 Gy fractions , five fractions per week 200 cGy twice per day in 6 fractions on days - 6 to - 4 with lung shielding at 10 Gy ( total dose : 1200 cGy ) 2 Gy fractions x 35 fractions ( total dose <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions given twice per day , 5 times per week ( total dose : 80.4 Gy for <Anatomical_site-START> oropharynx <Anatomical_site-END> ; 75.6 Gy for hypopharynx ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week over 7 weeks with 1.8 Gy fractions given in
DOSE-SITE	68.4 Gy ) 2.5 Gy fractions , five fractions per week 200 cGy twice per day in 6 fractions on days - 6 to - 4 with lung shielding at 10 Gy ( total dose : 1200 cGy ) 2 Gy fractions x 35 fractions ( total dose <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions given twice per day , 5 times per week ( total dose : 80.4 Gy for oropharynx ; 75.6 Gy for <Anatomical_site-START> hypopharynx <Anatomical_site-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week over 7 weeks with 1.8 Gy fractions given in
DOSE-SITE	per day in 6 fractions on days - 6 to - 4 with lung shielding at 10 Gy ( total dose : 1200 cGy ) 2 Gy fractions x 35 fractions ( total dose 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 80.4 Gy <RT_DOSE-END> for <Anatomical_site-START> oropharynx <Anatomical_site-END> ; 75.6 Gy for hypopharynx ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week over 7 weeks with 1.8 Gy fractions given in 30 fractions , for a total dose of 54 Gy 2.0 Gy x 20 fractions
DOSE-SITE	per day in 6 fractions on days - 6 to - 4 with lung shielding at 10 Gy ( total dose : 1200 cGy ) 2 Gy fractions x 35 fractions ( total dose 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 80.4 Gy <RT_DOSE-END> for oropharynx ; 75.6 Gy for <Anatomical_site-START> hypopharynx <Anatomical_site-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week over 7 weeks with 1.8 Gy fractions given in 30 fractions , for a total dose of 54 Gy 2.0 Gy x 20 fractions
DOSE-SITE	on days - 6 to - 4 with lung shielding at 10 Gy ( total dose : 1200 cGy ) 2 Gy fractions x 35 fractions ( total dose 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 80.4 Gy for <Anatomical_site-START> oropharynx <Anatomical_site-END> ; <RT_DOSE-START> 75.6 Gy <RT_DOSE-END> for hypopharynx ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week over 7 weeks with 1.8 Gy fractions given in 30 fractions , for a total dose of 54 Gy 2.0 Gy x 20 fractions ( total dose : 40
DOSE-SITE	on days - 6 to - 4 with lung shielding at 10 Gy ( total dose : 1200 cGy ) 2 Gy fractions x 35 fractions ( total dose 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 80.4 Gy for oropharynx ; <RT_DOSE-START> 75.6 Gy <RT_DOSE-END> for <Anatomical_site-START> hypopharynx <Anatomical_site-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week over 7 weeks with 1.8 Gy fractions given in 30 fractions , for a total dose of 54 Gy 2.0 Gy x 20 fractions ( total dose : 40
None	4 with lung shielding at 10 Gy ( total dose : 1200 cGy ) 2 Gy fractions x 35 fractions ( total dose 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 80.4 Gy for <Anatomical_site-START> oropharynx <Anatomical_site-END> ; 75.6 Gy for hypopharynx ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week over 7 weeks with 1.8 Gy fractions given in 30 fractions , for a total dose of 54 Gy 2.0 Gy x 20 fractions ( total dose : 40 Gy ) 1.8 Gy fractions
None	4 with lung shielding at 10 Gy ( total dose : 1200 cGy ) 2 Gy fractions x 35 fractions ( total dose 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 80.4 Gy for oropharynx ; 75.6 Gy for <Anatomical_site-START> hypopharynx <Anatomical_site-END> ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week over 7 weeks with 1.8 Gy fractions given in 30 fractions , for a total dose of 54 Gy 2.0 Gy x 20 fractions ( total dose : 40 Gy ) 1.8 Gy fractions
None	: 1200 cGy ) 2 Gy fractions x 35 fractions ( total dose 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 80.4 Gy for <Anatomical_site-START> oropharynx <Anatomical_site-END> ; 75.6 Gy for hypopharynx ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 times per week over 7 weeks with 1.8 Gy fractions given in 30 fractions , for a total dose of 54 Gy 2.0 Gy x 20 fractions ( total dose : 40 Gy ) 1.8 Gy fractions x 23 fractions , for a total dose of 41.4
None	: 1200 cGy ) 2 Gy fractions x 35 fractions ( total dose 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 80.4 Gy for oropharynx ; 75.6 Gy for <Anatomical_site-START> hypopharynx <Anatomical_site-END> ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 times per week over 7 weeks with 1.8 Gy fractions given in 30 fractions , for a total dose of 54 Gy 2.0 Gy x 20 fractions ( total dose : 40 Gy ) 1.8 Gy fractions x 23 fractions , for a total dose of 41.4
None	dose 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 80.4 Gy for <Anatomical_site-START> oropharynx <Anatomical_site-END> ; 75.6 Gy for hypopharynx ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week over 7 weeks with <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions given in 30 fractions , for a total dose of 54 Gy 2.0 Gy x 20 fractions ( total dose : 40 Gy ) 1.8 Gy fractions x 23 fractions , for a total dose of 41.4 Gy 2.75 Gy fractions x 20 fractions ( total dose : 55
None	dose 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 80.4 Gy for oropharynx ; 75.6 Gy for <Anatomical_site-START> hypopharynx <Anatomical_site-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week over 7 weeks with <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions given in 30 fractions , for a total dose of 54 Gy 2.0 Gy x 20 fractions ( total dose : 40 Gy ) 1.8 Gy fractions x 23 fractions , for a total dose of 41.4 Gy 2.75 Gy fractions x 20 fractions ( total dose : 55
None	week ( total dose : 80.4 Gy for <Anatomical_site-START> oropharynx <Anatomical_site-END> ; 75.6 Gy for hypopharynx ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week over 7 weeks with 1.8 Gy fractions given in 30 fractions , for a total dose of <RT_DOSE-START> 54 Gy <RT_DOSE-END> 2.0 Gy x 20 fractions ( total dose : 40 Gy ) 1.8 Gy fractions x 23 fractions , for a total dose of 41.4 Gy 2.75 Gy fractions x 20 fractions ( total dose : 55 Gy ) 1.5 Gy fractions x 12 fractions ( total dose
None	week ( total dose : 80.4 Gy for oropharynx ; 75.6 Gy for <Anatomical_site-START> hypopharynx <Anatomical_site-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week over 7 weeks with 1.8 Gy fractions given in 30 fractions , for a total dose of <RT_DOSE-START> 54 Gy <RT_DOSE-END> 2.0 Gy x 20 fractions ( total dose : 40 Gy ) 1.8 Gy fractions x 23 fractions , for a total dose of 41.4 Gy 2.75 Gy fractions x 20 fractions ( total dose : 55 Gy ) 1.5 Gy fractions x 12 fractions ( total dose
None	dose : 80.4 Gy for <Anatomical_site-START> oropharynx <Anatomical_site-END> ; 75.6 Gy for hypopharynx ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week over 7 weeks with 1.8 Gy fractions given in 30 fractions , for a total dose of 54 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 20 fractions ( total dose : 40 Gy ) 1.8 Gy fractions x 23 fractions , for a total dose of 41.4 Gy 2.75 Gy fractions x 20 fractions ( total dose : 55 Gy ) 1.5 Gy fractions x 12 fractions ( total dose 2.0 Gy fractions
None	dose : 80.4 Gy for oropharynx ; 75.6 Gy for <Anatomical_site-START> hypopharynx <Anatomical_site-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week over 7 weeks with 1.8 Gy fractions given in 30 fractions , for a total dose of 54 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 20 fractions ( total dose : 40 Gy ) 1.8 Gy fractions x 23 fractions , for a total dose of 41.4 Gy 2.75 Gy fractions x 20 fractions ( total dose : 55 Gy ) 1.5 Gy fractions x 12 fractions ( total dose 2.0 Gy fractions
None	for <Anatomical_site-START> hypopharynx <Anatomical_site-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week over 7 weeks with 1.8 Gy fractions given in 30 fractions , for a total dose of 54 Gy 2.0 Gy x 20 fractions ( total dose : <RT_DOSE-START> 40 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 23 fractions , for a total dose of 41.4 Gy 2.75 Gy fractions x 20 fractions ( total dose : 55 Gy ) 1.5 Gy fractions x 12 fractions ( total dose 2.0 Gy fractions x 20 fractions , for a total dose of
None	x 20 fractions , for a total dose of 40 Gy at a minimum : 1.8 Gy per day x 25 fractions ( total dose : 45 Gy ) , given over 5 weeks ; see articles for additional details 2 Gy fractions x 30 fractions ( total dose : <RT_DOSE-START> 60 Gy <RT_DOSE-END> ) , given 5 times per week 1.8 Gy fractions x 22 fractions ( total dose : 39.6 Gy ) 54.4 Gy 66 Gy 1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary <Anatomical_site-START> unresected tumors <Anatomical_site-END> , 1.8 to 2 Gy fractions (
None	Gy at a minimum : 1.8 Gy per day x 25 fractions ( total dose : 45 Gy ) , given over 5 weeks ; see articles for additional details 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 22 fractions ( total dose : 39.6 Gy ) 54.4 Gy 66 Gy 1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary <Anatomical_site-START> unresected tumors <Anatomical_site-END> , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) .
None	x 25 fractions ( total dose : 45 Gy ) , given over 5 weeks ; see articles for additional details 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week 1.8 Gy fractions x 22 fractions ( total dose : <RT_DOSE-START> 39.6 Gy <RT_DOSE-END> ) 54.4 Gy 66 Gy 1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary <Anatomical_site-START> unresected tumors <Anatomical_site-END> , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . Nodal areas not
None	x 25 fractions ( total dose : 45 Gy ) , given over 5 weeks ; see articles for additional details 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week 1.8 Gy fractions x 22 fractions ( total dose : <RT_DOSE-START> 39.6 Gy <RT_DOSE-END> ) 54.4 Gy 66 Gy 1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . <Anatomical_site-START> Post-operative areas <Anatomical_site-END> received 60 Gy . Nodal areas not
None	total dose : 45 Gy ) , given over 5 weeks ; see articles for additional details 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week 1.8 Gy fractions x 22 fractions ( total dose : 39.6 Gy ) <RT_DOSE-START> 54.4 Gy <RT_DOSE-END> 66 Gy 1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary <Anatomical_site-START> unresected tumors <Anatomical_site-END> , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received
None	total dose : 45 Gy ) , given over 5 weeks ; see articles for additional details 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week 1.8 Gy fractions x 22 fractions ( total dose : 39.6 Gy ) <RT_DOSE-START> 54.4 Gy <RT_DOSE-END> 66 Gy 1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . <Anatomical_site-START> Post-operative areas <Anatomical_site-END> received 60 Gy . Nodal areas not involved by tumor received
None	total dose : 45 Gy ) , given over 5 weeks ; see articles for additional details 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week 1.8 Gy fractions x 22 fractions ( total dose : 39.6 Gy ) <RT_DOSE-START> 54.4 Gy <RT_DOSE-END> 66 Gy 1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . <Anatomical_site-START> Nodal areas not involved by tumor <Anatomical_site-END> received
None	45 Gy ) , given over 5 weeks ; see articles for additional details 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week 1.8 Gy fractions x 22 fractions ( total dose : 39.6 Gy ) 54.4 Gy <RT_DOSE-START> 66 Gy <RT_DOSE-END> 1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary <Anatomical_site-START> unresected tumors <Anatomical_site-END> , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least 45
None	45 Gy ) , given over 5 weeks ; see articles for additional details 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week 1.8 Gy fractions x 22 fractions ( total dose : 39.6 Gy ) 54.4 Gy <RT_DOSE-START> 66 Gy <RT_DOSE-END> 1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . <Anatomical_site-START> Post-operative areas <Anatomical_site-END> received 60 Gy . Nodal areas not involved by tumor received at least 45
None	45 Gy ) , given over 5 weeks ; see articles for additional details 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week 1.8 Gy fractions x 22 fractions ( total dose : 39.6 Gy ) 54.4 Gy <RT_DOSE-START> 66 Gy <RT_DOSE-END> 1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . <Anatomical_site-START> Nodal areas not involved by tumor <Anatomical_site-END> received at least 45
None	, given over 5 weeks ; see articles for additional details 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week 1.8 Gy fractions x 22 fractions ( total dose : 39.6 Gy ) 54.4 Gy 66 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> for 28 fractions , for a total dose of 50.4 Gy to primary <Anatomical_site-START> unresected tumors <Anatomical_site-END> , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy .
None	, given over 5 weeks ; see articles for additional details 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week 1.8 Gy fractions x 22 fractions ( total dose : 39.6 Gy ) 54.4 Gy 66 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> for 28 fractions , for a total dose of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . <Anatomical_site-START> Post-operative areas <Anatomical_site-END> received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy .
None	, given over 5 weeks ; see articles for additional details 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week 1.8 Gy fractions x 22 fractions ( total dose : 39.6 Gy ) 54.4 Gy 66 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> for 28 fractions , for a total dose of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . <Anatomical_site-START> Nodal areas not involved by tumor <Anatomical_site-END> received at least 45 Gy .
None	2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week 1.8 Gy fractions x 22 fractions ( total dose : 39.6 Gy ) 54.4 Gy 66 Gy 1.80 Gy for 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> to primary <Anatomical_site-START> unresected tumors <Anatomical_site-END> , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to
None	2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week 1.8 Gy fractions x 22 fractions ( total dose : 39.6 Gy ) 54.4 Gy 66 Gy 1.80 Gy for 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . <Anatomical_site-START> Post-operative areas <Anatomical_site-END> received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to
None	2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week 1.8 Gy fractions x 22 fractions ( total dose : 39.6 Gy ) 54.4 Gy 66 Gy 1.80 Gy for 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . <Anatomical_site-START> Nodal areas not involved by tumor <Anatomical_site-END> received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to
None	2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week 1.8 Gy fractions x 22 fractions ( total dose : 39.6 Gy ) 54.4 Gy 66 Gy 1.80 Gy for 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to
DOSE-SITE	total dose : 60 Gy ) , given 5 times per week 1.8 Gy fractions x 22 fractions ( total dose : 39.6 Gy ) 54.4 Gy 66 Gy 1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary <Anatomical_site-START> unresected tumors <Anatomical_site-END> , 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to involved fields 30 Gy + 10 Gy to the
None	total dose : 60 Gy ) , given 5 times per week 1.8 Gy fractions x 22 fractions ( total dose : 39.6 Gy ) 54.4 Gy 66 Gy 1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary unresected tumors , <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions ( total dose : 65 to 70 Gy ) . <Anatomical_site-START> Post-operative areas <Anatomical_site-END> received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to involved fields 30 Gy + 10 Gy to the
None	total dose : 60 Gy ) , given 5 times per week 1.8 Gy fractions x 22 fractions ( total dose : 39.6 Gy ) 54.4 Gy 66 Gy 1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary unresected tumors , <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . <Anatomical_site-START> Nodal areas not involved by tumor <Anatomical_site-END> received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to involved fields 30 Gy + 10 Gy to the
None	total dose : 60 Gy ) , given 5 times per week 1.8 Gy fractions x 22 fractions ( total dose : 39.6 Gy ) 54.4 Gy 66 Gy 1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary unresected tumors , <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to involved fields 30 Gy + 10 Gy to the
None	total dose : 60 Gy ) , given 5 times per week 1.8 Gy fractions x 22 fractions ( total dose : 39.6 Gy ) 54.4 Gy 66 Gy 1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary unresected tumors , <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to <Anatomical_site-START> involved fields <Anatomical_site-END> 30 Gy + 10 Gy to the
DOSE-SITE	times per week 1.8 Gy fractions x 22 fractions ( total dose : 39.6 Gy ) 54.4 Gy 66 Gy 1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary <Anatomical_site-START> unresected tumors <Anatomical_site-END> , 1.8 to 2 Gy fractions ( total dose : 65 to <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to involved fields 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose
None	times per week 1.8 Gy fractions x 22 fractions ( total dose : 39.6 Gy ) 54.4 Gy 66 Gy 1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> ) . <Anatomical_site-START> Post-operative areas <Anatomical_site-END> received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to involved fields 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose
None	times per week 1.8 Gy fractions x 22 fractions ( total dose : 39.6 Gy ) 54.4 Gy 66 Gy 1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> ) . Post-operative areas received 60 Gy . <Anatomical_site-START> Nodal areas not involved by tumor <Anatomical_site-END> received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to involved fields 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose
None	times per week 1.8 Gy fractions x 22 fractions ( total dose : 39.6 Gy ) 54.4 Gy 66 Gy 1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to involved fields 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose
None	times per week 1.8 Gy fractions x 22 fractions ( total dose : 39.6 Gy ) 54.4 Gy 66 Gy 1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to <Anatomical_site-START> involved fields <Anatomical_site-END> 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose
None	times per week 1.8 Gy fractions x 22 fractions ( total dose : 39.6 Gy ) 54.4 Gy 66 Gy 1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to involved fields 30 Gy + 10 Gy to the <Anatomical_site-START> involved field <Anatomical_site-END> 1.50-Gy fractions with a total dose
None	( total dose : 39.6 Gy ) 54.4 Gy 66 Gy 1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary <Anatomical_site-START> unresected tumors <Anatomical_site-END> , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received <RT_DOSE-START> 60 Gy <RT_DOSE-END> . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to involved fields 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice
DOSE-SITE	( total dose : 39.6 Gy ) 54.4 Gy 66 Gy 1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . <Anatomical_site-START> Post-operative areas <Anatomical_site-END> received <RT_DOSE-START> 60 Gy <RT_DOSE-END> . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to involved fields 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice
None	( total dose : 39.6 Gy ) 54.4 Gy 66 Gy 1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received <RT_DOSE-START> 60 Gy <RT_DOSE-END> . <Anatomical_site-START> Nodal areas not involved by tumor <Anatomical_site-END> received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to involved fields 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice
None	( total dose : 39.6 Gy ) 54.4 Gy 66 Gy 1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received <RT_DOSE-START> 60 Gy <RT_DOSE-END> . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to involved fields 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice
None	( total dose : 39.6 Gy ) 54.4 Gy 66 Gy 1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received <RT_DOSE-START> 60 Gy <RT_DOSE-END> . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to <Anatomical_site-START> involved fields <Anatomical_site-END> 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice
None	( total dose : 39.6 Gy ) 54.4 Gy 66 Gy 1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received <RT_DOSE-START> 60 Gy <RT_DOSE-END> . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to involved fields 30 Gy + 10 Gy to the <Anatomical_site-START> involved field <Anatomical_site-END> 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice
None	1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary <Anatomical_site-START> unresected tumors <Anatomical_site-END> , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least <RT_DOSE-START> 45 Gy <RT_DOSE-END> . 36 Gy in 18 fractions , with 4 Gy boost to involved fields 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given (
None	1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . <Anatomical_site-START> Post-operative areas <Anatomical_site-END> received 60 Gy . Nodal areas not involved by tumor received at least <RT_DOSE-START> 45 Gy <RT_DOSE-END> . 36 Gy in 18 fractions , with 4 Gy boost to involved fields 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given (
DOSE-SITE	1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . <Anatomical_site-START> Nodal areas not involved by tumor <Anatomical_site-END> received at least <RT_DOSE-START> 45 Gy <RT_DOSE-END> . 36 Gy in 18 fractions , with 4 Gy boost to involved fields 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given (
None	1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least <RT_DOSE-START> 45 Gy <RT_DOSE-END> . 36 Gy in 18 fractions , with 4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to involved fields 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given (
None	1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least <RT_DOSE-START> 45 Gy <RT_DOSE-END> . 36 Gy in 18 fractions , with 4 Gy boost to <Anatomical_site-START> involved fields <Anatomical_site-END> 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given (
None	1.80 Gy for 28 fractions , for a total dose of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least <RT_DOSE-START> 45 Gy <RT_DOSE-END> . 36 Gy in 18 fractions , with 4 Gy boost to involved fields 30 Gy + 10 Gy to the <Anatomical_site-START> involved field <Anatomical_site-END> 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given (
None	28 fractions , for a total dose of 50.4 Gy to primary <Anatomical_site-START> unresected tumors <Anatomical_site-END> , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions , with 4 Gy boost to involved fields 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and
None	28 fractions , for a total dose of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . <Anatomical_site-START> Post-operative areas <Anatomical_site-END> received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions , with 4 Gy boost to involved fields 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and
None	28 fractions , for a total dose of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . <Anatomical_site-START> Nodal areas not involved by tumor <Anatomical_site-END> received at least 45 Gy . <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions , with 4 Gy boost to involved fields 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and
None	28 fractions , for a total dose of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions , with 4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to involved fields 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and
None	28 fractions , for a total dose of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions , with 4 Gy boost to <Anatomical_site-START> involved fields <Anatomical_site-END> 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and
None	28 fractions , for a total dose of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions , with 4 Gy boost to involved fields 30 Gy + 10 Gy to the <Anatomical_site-START> involved field <Anatomical_site-END> 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and
None	of 50.4 Gy to primary <Anatomical_site-START> unresected tumors <Anatomical_site-END> , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and total duration of treatment was not specified
None	of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . <Anatomical_site-START> Post-operative areas <Anatomical_site-END> received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and total duration of treatment was not specified
None	of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . <Anatomical_site-START> Nodal areas not involved by tumor <Anatomical_site-END> received at least 45 Gy . 36 Gy in 18 fractions , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and total duration of treatment was not specified
DOSE-SITE	of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> <Anatomical_site-START> boost <Anatomical_site-END> to involved fields 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and total duration of treatment was not specified
DOSE-SITE	of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to <Anatomical_site-START> involved fields <Anatomical_site-END> 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and total duration of treatment was not specified
None	of 50.4 Gy to primary unresected tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 30 Gy + 10 Gy to the <Anatomical_site-START> involved field <Anatomical_site-END> 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and total duration of treatment was not specified
None	tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . <Anatomical_site-START> Post-operative areas <Anatomical_site-END> received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to involved fields <RT_DOSE-START> 30 Gy <RT_DOSE-END> + 10 Gy to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12
None	tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . <Anatomical_site-START> Nodal areas not involved by tumor <Anatomical_site-END> received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to involved fields <RT_DOSE-START> 30 Gy <RT_DOSE-END> + 10 Gy to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12
None	tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to involved fields <RT_DOSE-START> 30 Gy <RT_DOSE-END> + 10 Gy to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12
None	tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to <Anatomical_site-START> involved fields <Anatomical_site-END> <RT_DOSE-START> 30 Gy <RT_DOSE-END> + 10 Gy to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12
None	tumors , 1.8 to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to involved fields <RT_DOSE-START> 30 Gy <RT_DOSE-END> + 10 Gy to the <Anatomical_site-START> involved field <Anatomical_site-END> 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12
None	to 2 Gy fractions ( total dose : 65 to 70 Gy ) . <Anatomical_site-START> Post-operative areas <Anatomical_site-END> received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to involved fields 30 Gy + <RT_DOSE-START> 10 Gy <RT_DOSE-END> to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12 Gy over 3
None	to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . <Anatomical_site-START> Nodal areas not involved by tumor <Anatomical_site-END> received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to involved fields 30 Gy + <RT_DOSE-START> 10 Gy <RT_DOSE-END> to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12 Gy over 3
None	to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to involved fields 30 Gy + <RT_DOSE-START> 10 Gy <RT_DOSE-END> to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12 Gy over 3
None	to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to <Anatomical_site-START> involved fields <Anatomical_site-END> 30 Gy + <RT_DOSE-START> 10 Gy <RT_DOSE-END> to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12 Gy over 3
DOSE-SITE	to 2 Gy fractions ( total dose : 65 to 70 Gy ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to involved fields 30 Gy + <RT_DOSE-START> 10 Gy <RT_DOSE-END> to the <Anatomical_site-START> involved field <Anatomical_site-END> 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12 Gy over 3
None	: 65 to 70 Gy ) . <Anatomical_site-START> Post-operative areas <Anatomical_site-END> received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to involved fields 30 Gy + 10 Gy to the involved field <RT_DOSE-START> 1.50-Gy <RT_DOSE-END> fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12 Gy over 3 days ( days - 6 to
None	: 65 to 70 Gy ) . Post-operative areas received 60 Gy . <Anatomical_site-START> Nodal areas not involved by tumor <Anatomical_site-END> received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to involved fields 30 Gy + 10 Gy to the involved field <RT_DOSE-START> 1.50-Gy <RT_DOSE-END> fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12 Gy over 3 days ( days - 6 to
None	: 65 to 70 Gy ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to involved fields 30 Gy + 10 Gy to the involved field <RT_DOSE-START> 1.50-Gy <RT_DOSE-END> fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12 Gy over 3 days ( days - 6 to
None	: 65 to 70 Gy ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to <Anatomical_site-START> involved fields <Anatomical_site-END> 30 Gy + 10 Gy to the involved field <RT_DOSE-START> 1.50-Gy <RT_DOSE-END> fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12 Gy over 3 days ( days - 6 to
None	: 65 to 70 Gy ) . Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to involved fields 30 Gy + 10 Gy to the <Anatomical_site-START> involved field <Anatomical_site-END> <RT_DOSE-START> 1.50-Gy <RT_DOSE-END> fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12 Gy over 3 days ( days - 6 to
None	<Anatomical_site-START> Post-operative areas <Anatomical_site-END> received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to involved fields 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose of <RT_DOSE-START> 10 Gy <RT_DOSE-END> over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12 Gy over 3 days ( days - 6 to - 4 ) in fractions 50.4 Gy
None	Post-operative areas received 60 Gy . <Anatomical_site-START> Nodal areas not involved by tumor <Anatomical_site-END> received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to involved fields 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose of <RT_DOSE-START> 10 Gy <RT_DOSE-END> over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12 Gy over 3 days ( days - 6 to - 4 ) in fractions 50.4 Gy
None	Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to involved fields 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose of <RT_DOSE-START> 10 Gy <RT_DOSE-END> over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12 Gy over 3 days ( days - 6 to - 4 ) in fractions 50.4 Gy
None	Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to <Anatomical_site-START> involved fields <Anatomical_site-END> 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose of <RT_DOSE-START> 10 Gy <RT_DOSE-END> over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12 Gy over 3 days ( days - 6 to - 4 ) in fractions 50.4 Gy
None	Post-operative areas received 60 Gy . Nodal areas not involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to involved fields 30 Gy + 10 Gy to the <Anatomical_site-START> involved field <Anatomical_site-END> 1.50-Gy fractions with a total dose of <RT_DOSE-START> 10 Gy <RT_DOSE-END> over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12 Gy over 3 days ( days - 6 to - 4 ) in fractions 50.4 Gy
None	involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to involved fields 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> total of 54 Gy given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12 Gy over 3 days ( days - 6 to - 4 ) in fractions 50.4 Gy total to a total dose of at least 40 Gy
None	involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to <Anatomical_site-START> involved fields <Anatomical_site-END> 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> total of 54 Gy given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12 Gy over 3 days ( days - 6 to - 4 ) in fractions 50.4 Gy total to a total dose of at least 40 Gy
None	involved by tumor received at least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to involved fields 30 Gy + 10 Gy to the <Anatomical_site-START> involved field <Anatomical_site-END> 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> total of 54 Gy given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12 Gy over 3 days ( days - 6 to - 4 ) in fractions 50.4 Gy total to a total dose of at least 40 Gy
None	least 45 Gy . 36 Gy in 18 fractions , with 4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to involved fields 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of <RT_DOSE-START> 54 Gy <RT_DOSE-END> given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12 Gy over 3 days ( days - 6 to - 4 ) in fractions 50.4 Gy total to a total dose of at least 40 Gy 2 Gy once on
None	least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to <Anatomical_site-START> involved fields <Anatomical_site-END> 30 Gy + 10 Gy to the involved field 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of <RT_DOSE-START> 54 Gy <RT_DOSE-END> given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12 Gy over 3 days ( days - 6 to - 4 ) in fractions 50.4 Gy total to a total dose of at least 40 Gy 2 Gy once on
None	least 45 Gy . 36 Gy in 18 fractions , with 4 Gy boost to involved fields 30 Gy + 10 Gy to the <Anatomical_site-START> involved field <Anatomical_site-END> 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of <RT_DOSE-START> 54 Gy <RT_DOSE-END> given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12 Gy over 3 days ( days - 6 to - 4 ) in fractions 50.4 Gy total to a total dose of at least 40 Gy 2 Gy once on
None	+ 10 Gy to the <Anatomical_site-START> involved field <Anatomical_site-END> 1.50-Gy fractions with a total dose of 10 Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and total duration of treatment was not specified ) with a total dose of <RT_DOSE-START> 12 Gy <RT_DOSE-END> over 3 days ( days - 6 to - 4 ) in fractions 50.4 Gy total to a total dose of at least 40 Gy 2 Gy once on day - 1 2 Gy at a rate of 0.07 to 0.20 Gy / min on day 0 to
None	Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12 Gy over 3 days ( days - 6 to - 4 ) in fractions <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> total to a total dose of at least 40 Gy 2 Gy once on day - 1 2 Gy at a rate of 0.07 to 0.20 Gy / min on day 0 to the <Anatomical_site-START> nasal cavity <Anatomical_site-END> and surrounding sinuses , 56 Gy in 28 fractions , once per day
None	Gy over 3 days using twice per day fractions 44.8 Gy total of 54 Gy given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12 Gy over 3 days ( days - 6 to - 4 ) in fractions <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> total to a total dose of at least 40 Gy 2 Gy once on day - 1 2 Gy at a rate of 0.07 to 0.20 Gy / min on day 0 to the nasal cavity and surrounding <Anatomical_site-START> sinuses <Anatomical_site-END> , 56 Gy in 28 fractions , once per day
None	Gy total of 54 Gy given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12 Gy over 3 days ( days - 6 to - 4 ) in fractions 50.4 Gy total to a total dose of at least <RT_DOSE-START> 40 Gy <RT_DOSE-END> 2 Gy once on day - 1 2 Gy at a rate of 0.07 to 0.20 Gy / min on day 0 to the <Anatomical_site-START> nasal cavity <Anatomical_site-END> and surrounding sinuses , 56 Gy in 28 fractions , once per day , five days per week total dose 70 to 74
None	Gy total of 54 Gy given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12 Gy over 3 days ( days - 6 to - 4 ) in fractions 50.4 Gy total to a total dose of at least <RT_DOSE-START> 40 Gy <RT_DOSE-END> 2 Gy once on day - 1 2 Gy at a rate of 0.07 to 0.20 Gy / min on day 0 to the nasal cavity and surrounding <Anatomical_site-START> sinuses <Anatomical_site-END> , 56 Gy in 28 fractions , once per day , five days per week total dose 70 to 74
None	of 54 Gy given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12 Gy over 3 days ( days - 6 to - 4 ) in fractions 50.4 Gy total to a total dose of at least 40 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> once on day - 1 2 Gy at a rate of 0.07 to 0.20 Gy / min on day 0 to the <Anatomical_site-START> nasal cavity <Anatomical_site-END> and surrounding sinuses , 56 Gy in 28 fractions , once per day , five days per week total dose 70 to 74 Gy 50.4
None	of 54 Gy given ( dose per fraction and total duration of treatment was not specified ) with a total dose of 12 Gy over 3 days ( days - 6 to - 4 ) in fractions 50.4 Gy total to a total dose of at least 40 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> once on day - 1 2 Gy at a rate of 0.07 to 0.20 Gy / min on day 0 to the nasal cavity and surrounding <Anatomical_site-START> sinuses <Anatomical_site-END> , 56 Gy in 28 fractions , once per day , five days per week total dose 70 to 74 Gy 50.4
None	and total duration of treatment was not specified ) with a total dose of 12 Gy over 3 days ( days - 6 to - 4 ) in fractions 50.4 Gy total to a total dose of at least 40 Gy 2 Gy once on day - 1 <RT_DOSE-START> 2 Gy <RT_DOSE-END> at a rate of 0.07 to 0.20 Gy / min on day 0 to the <Anatomical_site-START> nasal cavity <Anatomical_site-END> and surrounding sinuses , 56 Gy in 28 fractions , once per day , five days per week total dose 70 to 74 Gy 50.4 Gy of proton or photon ( intensity modulated
None	and total duration of treatment was not specified ) with a total dose of 12 Gy over 3 days ( days - 6 to - 4 ) in fractions 50.4 Gy total to a total dose of at least 40 Gy 2 Gy once on day - 1 <RT_DOSE-START> 2 Gy <RT_DOSE-END> at a rate of 0.07 to 0.20 Gy / min on day 0 to the nasal cavity and surrounding <Anatomical_site-START> sinuses <Anatomical_site-END> , 56 Gy in 28 fractions , once per day , five days per week total dose 70 to 74 Gy 50.4 Gy of proton or photon ( intensity modulated
DOSE-SITE	- 4 ) in fractions 50.4 Gy total to a total dose of at least 40 Gy 2 Gy once on day - 1 2 Gy at a rate of 0.07 to 0.20 Gy / min on day 0 to the <Anatomical_site-START> nasal cavity <Anatomical_site-END> and surrounding sinuses , <RT_DOSE-START> 56 Gy <RT_DOSE-END> in 28 fractions , once per day , five days per week total dose 70 to 74 Gy 50.4 Gy of proton or photon ( intensity modulated ) radiation in 28 fractions 3 Gy fractions , five fractions per week 36 Gy to areas of initial bulky disease
DOSE-SITE	- 4 ) in fractions 50.4 Gy total to a total dose of at least 40 Gy 2 Gy once on day - 1 2 Gy at a rate of 0.07 to 0.20 Gy / min on day 0 to the nasal cavity and surrounding <Anatomical_site-START> sinuses <Anatomical_site-END> , <RT_DOSE-START> 56 Gy <RT_DOSE-END> in 28 fractions , once per day , five days per week total dose 70 to 74 Gy 50.4 Gy of proton or photon ( intensity modulated ) radiation in 28 fractions 3 Gy fractions , five fractions per week 36 Gy to areas of initial bulky disease
None	- 4 ) in fractions 50.4 Gy total to a total dose of at least 40 Gy 2 Gy once on day - 1 2 Gy at a rate of 0.07 to 0.20 Gy / min on day 0 to the nasal cavity and surrounding sinuses , <RT_DOSE-START> 56 Gy <RT_DOSE-END> in 28 fractions , once per day , five days per week total dose 70 to 74 Gy 50.4 Gy of proton or photon ( intensity modulated ) radiation in 28 fractions 3 Gy fractions , five fractions per week 36 Gy to areas of initial <Anatomical_site-START> bulky disease <Anatomical_site-END>
None	40 Gy 2 Gy once on day - 1 2 Gy at a rate of 0.07 to 0.20 Gy / min on day 0 to the <Anatomical_site-START> nasal cavity <Anatomical_site-END> and surrounding sinuses , 56 Gy in 28 fractions , once per day , five days per week total dose 70 to <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> 50.4 Gy of proton or photon ( intensity modulated ) radiation in 28 fractions 3 Gy fractions , five fractions per week 36 Gy to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in
None	40 Gy 2 Gy once on day - 1 2 Gy at a rate of 0.07 to 0.20 Gy / min on day 0 to the nasal cavity and surrounding <Anatomical_site-START> sinuses <Anatomical_site-END> , 56 Gy in 28 fractions , once per day , five days per week total dose 70 to <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> 50.4 Gy of proton or photon ( intensity modulated ) radiation in 28 fractions 3 Gy fractions , five fractions per week 36 Gy to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in
None	40 Gy 2 Gy once on day - 1 2 Gy at a rate of 0.07 to 0.20 Gy / min on day 0 to the nasal cavity and surrounding sinuses , 56 Gy in 28 fractions , once per day , five days per week total dose <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> 50.4 Gy of proton or photon ( intensity modulated ) radiation in 28 fractions 3 Gy fractions , five fractions per week 36 Gy to areas of initial <Anatomical_site-START> bulky disease <Anatomical_site-END> to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in
None	once on day - 1 2 Gy at a rate of 0.07 to 0.20 Gy / min on day 0 to the <Anatomical_site-START> nasal cavity <Anatomical_site-END> and surrounding sinuses , 56 Gy in 28 fractions , once per day , five days per week total dose 70 to 74 Gy <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> of proton or photon ( intensity modulated ) radiation in 28 fractions 3 Gy fractions , five fractions per week 36 Gy to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks :
None	once on day - 1 2 Gy at a rate of 0.07 to 0.20 Gy / min on day 0 to the nasal cavity and surrounding <Anatomical_site-START> sinuses <Anatomical_site-END> , 56 Gy in 28 fractions , once per day , five days per week total dose 70 to 74 Gy <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> of proton or photon ( intensity modulated ) radiation in 28 fractions 3 Gy fractions , five fractions per week 36 Gy to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks :
None	once on day - 1 2 Gy at a rate of 0.07 to 0.20 Gy / min on day 0 to the nasal cavity and surrounding sinuses , 56 Gy in 28 fractions , once per day , five days per week total dose 70 to 74 Gy <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> of proton or photon ( intensity modulated ) radiation in 28 fractions 3 Gy fractions , five fractions per week 36 Gy to areas of initial <Anatomical_site-START> bulky disease <Anatomical_site-END> to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks :
None	Gy / min on day 0 to the <Anatomical_site-START> nasal cavity <Anatomical_site-END> and surrounding sinuses , 56 Gy in 28 fractions , once per day , five days per week total dose 70 to 74 Gy 50.4 Gy of proton or photon ( intensity modulated ) radiation in 28 fractions <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions , five fractions per week 36 Gy to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and 14 Gy to the boost field , for total
None	Gy / min on day 0 to the nasal cavity and surrounding <Anatomical_site-START> sinuses <Anatomical_site-END> , 56 Gy in 28 fractions , once per day , five days per week total dose 70 to 74 Gy 50.4 Gy of proton or photon ( intensity modulated ) radiation in 28 fractions <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions , five fractions per week 36 Gy to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and 14 Gy to the boost field , for total
None	Gy / min on day 0 to the nasal cavity and surrounding sinuses , 56 Gy in 28 fractions , once per day , five days per week total dose 70 to 74 Gy 50.4 Gy of proton or photon ( intensity modulated ) radiation in 28 fractions <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions , five fractions per week 36 Gy to areas of initial <Anatomical_site-START> bulky disease <Anatomical_site-END> to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and 14 Gy to the boost field , for total
None	Gy / min on day 0 to the nasal cavity and surrounding sinuses , 56 Gy in 28 fractions , once per day , five days per week total dose 70 to 74 Gy 50.4 Gy of proton or photon ( intensity modulated ) radiation in 28 fractions <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions , five fractions per week 36 Gy to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of <Anatomical_site-START> regional <Anatomical_site-END> treatment and 14 Gy to the boost field , for total
None	Gy / min on day 0 to the nasal cavity and surrounding sinuses , 56 Gy in 28 fractions , once per day , five days per week total dose 70 to 74 Gy 50.4 Gy of proton or photon ( intensity modulated ) radiation in 28 fractions <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions , five fractions per week 36 Gy to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and 14 Gy to the <Anatomical_site-START> boost field <Anatomical_site-END> , for total
None	<Anatomical_site-START> nasal cavity <Anatomical_site-END> and surrounding sinuses , 56 Gy in 28 fractions , once per day , five days per week total dose 70 to 74 Gy 50.4 Gy of proton or photon ( intensity modulated ) radiation in 28 fractions 3 Gy fractions , five fractions per week <RT_DOSE-START> 36 Gy <RT_DOSE-END> to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and 14 Gy to the boost field , for total dose of 64 Gy to 56 Gy in
None	nasal cavity and surrounding <Anatomical_site-START> sinuses <Anatomical_site-END> , 56 Gy in 28 fractions , once per day , five days per week total dose 70 to 74 Gy 50.4 Gy of proton or photon ( intensity modulated ) radiation in 28 fractions 3 Gy fractions , five fractions per week <RT_DOSE-START> 36 Gy <RT_DOSE-END> to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and 14 Gy to the boost field , for total dose of 64 Gy to 56 Gy in
DOSE-SITE	nasal cavity and surrounding sinuses , 56 Gy in 28 fractions , once per day , five days per week total dose 70 to 74 Gy 50.4 Gy of proton or photon ( intensity modulated ) radiation in 28 fractions 3 Gy fractions , five fractions per week <RT_DOSE-START> 36 Gy <RT_DOSE-END> to areas of initial <Anatomical_site-START> bulky disease <Anatomical_site-END> to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and 14 Gy to the boost field , for total dose of 64 Gy to 56 Gy in
None	nasal cavity and surrounding sinuses , 56 Gy in 28 fractions , once per day , five days per week total dose 70 to 74 Gy 50.4 Gy of proton or photon ( intensity modulated ) radiation in 28 fractions 3 Gy fractions , five fractions per week <RT_DOSE-START> 36 Gy <RT_DOSE-END> to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of <Anatomical_site-START> regional <Anatomical_site-END> treatment and 14 Gy to the boost field , for total dose of 64 Gy to 56 Gy in
None	nasal cavity and surrounding sinuses , 56 Gy in 28 fractions , once per day , five days per week total dose 70 to 74 Gy 50.4 Gy of proton or photon ( intensity modulated ) radiation in 28 fractions 3 Gy fractions , five fractions per week <RT_DOSE-START> 36 Gy <RT_DOSE-END> to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and 14 Gy to the <Anatomical_site-START> boost field <Anatomical_site-END> , for total dose of 64 Gy to 56 Gy in
None	fractions , once per day , five days per week total dose 70 to 74 Gy 50.4 Gy of proton or photon ( intensity modulated ) radiation in 28 fractions 3 Gy fractions , five fractions per week 36 Gy to areas of initial <Anatomical_site-START> bulky disease <Anatomical_site-END> to <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and 14 Gy to the boost field , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy
None	fractions , once per day , five days per week total dose 70 to 74 Gy 50.4 Gy of proton or photon ( intensity modulated ) radiation in 28 fractions 3 Gy fractions , five fractions per week 36 Gy to areas of initial bulky disease to <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of <Anatomical_site-START> regional <Anatomical_site-END> treatment and 14 Gy to the boost field , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy
None	fractions , once per day , five days per week total dose 70 to 74 Gy 50.4 Gy of proton or photon ( intensity modulated ) radiation in 28 fractions 3 Gy fractions , five fractions per week 36 Gy to areas of initial bulky disease to <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and 14 Gy to the <Anatomical_site-START> boost field <Anatomical_site-END> , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy
None	per day , five days per week total dose 70 to 74 Gy 50.4 Gy of proton or photon ( intensity modulated ) radiation in 28 fractions 3 Gy fractions , five fractions per week 36 Gy to areas of initial <Anatomical_site-START> bulky disease <Anatomical_site-END> to 45 Gy <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and 14 Gy to the boost field , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18
None	per day , five days per week total dose 70 to 74 Gy 50.4 Gy of proton or photon ( intensity modulated ) radiation in 28 fractions 3 Gy fractions , five fractions per week 36 Gy to areas of initial bulky disease to 45 Gy in <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of <Anatomical_site-START> regional <Anatomical_site-END> treatment and 14 Gy to the boost field , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18
None	per day , five days per week total dose 70 to 74 Gy 50.4 Gy of proton or photon ( intensity modulated ) radiation in 28 fractions 3 Gy fractions , five fractions per week 36 Gy to areas of initial bulky disease to 45 Gy in <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and 14 Gy to the <Anatomical_site-START> boost field <Anatomical_site-END> , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18
None	days per week total dose 70 to 74 Gy 50.4 Gy of proton or photon ( intensity modulated ) radiation in 28 fractions 3 Gy fractions , five fractions per week 36 Gy to areas of initial <Anatomical_site-START> bulky disease <Anatomical_site-END> to 45 Gy in 1.5-Gy fractions to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and 14 Gy to the boost field , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18 fractions of 2.00 Gy per
None	days per week total dose 70 to 74 Gy 50.4 Gy of proton or photon ( intensity modulated ) radiation in 28 fractions 3 Gy fractions , five fractions per week 36 Gy to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of <Anatomical_site-START> regional <Anatomical_site-END> treatment and 14 Gy to the boost field , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18 fractions of 2.00 Gy per
None	days per week total dose 70 to 74 Gy 50.4 Gy of proton or photon ( intensity modulated ) radiation in 28 fractions 3 Gy fractions , five fractions per week 36 Gy to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and 14 Gy to the <Anatomical_site-START> boost field <Anatomical_site-END> , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18 fractions of 2.00 Gy per
None	total dose 70 to 74 Gy 50.4 Gy of proton or photon ( intensity modulated ) radiation in 28 fractions 3 Gy fractions , five fractions per week 36 Gy to areas of initial <Anatomical_site-START> bulky disease <Anatomical_site-END> to 45 Gy in 1.5-Gy fractions to 30 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and 14 Gy to the boost field , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18 fractions of 2.00 Gy per fraction
None	total dose 70 to 74 Gy 50.4 Gy of proton or photon ( intensity modulated ) radiation in 28 fractions 3 Gy fractions , five fractions per week 36 Gy to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions total of 32 fractions in 6.4 weeks : 50 Gy of <Anatomical_site-START> regional <Anatomical_site-END> treatment and 14 Gy to the boost field , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18 fractions of 2.00 Gy per fraction
None	total dose 70 to 74 Gy 50.4 Gy of proton or photon ( intensity modulated ) radiation in 28 fractions 3 Gy fractions , five fractions per week 36 Gy to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and 14 Gy to the <Anatomical_site-START> boost field <Anatomical_site-END> , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18 fractions of 2.00 Gy per fraction
None	proton or photon ( intensity modulated ) radiation in 28 fractions 3 Gy fractions , five fractions per week 36 Gy to areas of initial <Anatomical_site-START> bulky disease <Anatomical_site-END> to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : <RT_DOSE-START> 50 Gy <RT_DOSE-END> of regional treatment and 14 Gy to the boost field , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18 fractions of 2.00 Gy per fraction 55 Gy ) 35 Gy in 20 fractions 45 Gy
DOSE-SITE	proton or photon ( intensity modulated ) radiation in 28 fractions 3 Gy fractions , five fractions per week 36 Gy to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : <RT_DOSE-START> 50 Gy <RT_DOSE-END> of <Anatomical_site-START> regional <Anatomical_site-END> treatment and 14 Gy to the boost field , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18 fractions of 2.00 Gy per fraction 55 Gy ) 35 Gy in 20 fractions 45 Gy
None	proton or photon ( intensity modulated ) radiation in 28 fractions 3 Gy fractions , five fractions per week 36 Gy to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : <RT_DOSE-START> 50 Gy <RT_DOSE-END> of regional treatment and 14 Gy to the <Anatomical_site-START> boost field <Anatomical_site-END> , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18 fractions of 2.00 Gy per fraction 55 Gy ) 35 Gy in 20 fractions 45 Gy
None	) radiation in 28 fractions 3 Gy fractions , five fractions per week 36 Gy to areas of initial <Anatomical_site-START> bulky disease <Anatomical_site-END> to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and <RT_DOSE-START> 14 Gy <RT_DOSE-END> to the boost field , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18 fractions of 2.00 Gy per fraction 55 Gy ) 35 Gy in 20 fractions 45 Gy total 800 cGy once per
None	) radiation in 28 fractions 3 Gy fractions , five fractions per week 36 Gy to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of <Anatomical_site-START> regional <Anatomical_site-END> treatment and <RT_DOSE-START> 14 Gy <RT_DOSE-END> to the boost field , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18 fractions of 2.00 Gy per fraction 55 Gy ) 35 Gy in 20 fractions 45 Gy total 800 cGy once per
DOSE-SITE	) radiation in 28 fractions 3 Gy fractions , five fractions per week 36 Gy to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and <RT_DOSE-START> 14 Gy <RT_DOSE-END> to the <Anatomical_site-START> boost field <Anatomical_site-END> , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18 fractions of 2.00 Gy per fraction 55 Gy ) 35 Gy in 20 fractions 45 Gy total 800 cGy once per
None	fractions per week 36 Gy to areas of initial <Anatomical_site-START> bulky disease <Anatomical_site-END> to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and 14 Gy to the boost field , for total dose of <RT_DOSE-START> 64 Gy <RT_DOSE-END> to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18 fractions of 2.00 Gy per fraction 55 Gy ) 35 Gy in 20 fractions 45 Gy total 800 cGy once per day on days - 11 to - 1 ( 10 fractions
None	fractions per week 36 Gy to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of <Anatomical_site-START> regional <Anatomical_site-END> treatment and 14 Gy to the boost field , for total dose of <RT_DOSE-START> 64 Gy <RT_DOSE-END> to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18 fractions of 2.00 Gy per fraction 55 Gy ) 35 Gy in 20 fractions 45 Gy total 800 cGy once per day on days - 11 to - 1 ( 10 fractions
None	fractions per week 36 Gy to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and 14 Gy to the <Anatomical_site-START> boost field <Anatomical_site-END> , for total dose of <RT_DOSE-START> 64 Gy <RT_DOSE-END> to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18 fractions of 2.00 Gy per fraction 55 Gy ) 35 Gy in 20 fractions 45 Gy total 800 cGy once per day on days - 11 to - 1 ( 10 fractions
None	week 36 Gy to areas of initial <Anatomical_site-START> bulky disease <Anatomical_site-END> to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and 14 Gy to the boost field , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction 55 Gy ) 35 Gy in 20 fractions 45 Gy total 800 cGy once per day on days - 11 to - 1 ( 10 fractions
None	week 36 Gy to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of <Anatomical_site-START> regional <Anatomical_site-END> treatment and 14 Gy to the boost field , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction 55 Gy ) 35 Gy in 20 fractions 45 Gy total 800 cGy once per day on days - 11 to - 1 ( 10 fractions
None	week 36 Gy to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and 14 Gy to the <Anatomical_site-START> boost field <Anatomical_site-END> , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction 55 Gy ) 35 Gy in 20 fractions 45 Gy total 800 cGy once per day on days - 11 to - 1 ( 10 fractions
None	week 36 Gy to areas of initial <Anatomical_site-START> bulky disease <Anatomical_site-END> to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and 14 Gy to the boost field , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction 55 Gy ) 35 Gy in 20 fractions 45 Gy total 800 cGy once per day on days - 11 to - 1 ( 10 fractions
None	week 36 Gy to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of <Anatomical_site-START> regional <Anatomical_site-END> treatment and 14 Gy to the boost field , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction 55 Gy ) 35 Gy in 20 fractions 45 Gy total 800 cGy once per day on days - 11 to - 1 ( 10 fractions
None	week 36 Gy to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and 14 Gy to the <Anatomical_site-START> boost field <Anatomical_site-END> , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction 55 Gy ) 35 Gy in 20 fractions 45 Gy total 800 cGy once per day on days - 11 to - 1 ( 10 fractions
None	week 36 Gy to areas of initial <Anatomical_site-START> bulky disease <Anatomical_site-END> to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and 14 Gy to the boost field , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18 fractions of 2.00 Gy per fraction <RT_DOSE-START> 55 Gy <RT_DOSE-END> ) 35 Gy in 20 fractions 45 Gy total 800 cGy once per day on days - 11 to - 1 ( 10 fractions
None	week 36 Gy to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of <Anatomical_site-START> regional <Anatomical_site-END> treatment and 14 Gy to the boost field , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18 fractions of 2.00 Gy per fraction <RT_DOSE-START> 55 Gy <RT_DOSE-END> ) 35 Gy in 20 fractions 45 Gy total 800 cGy once per day on days - 11 to - 1 ( 10 fractions
None	week 36 Gy to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and 14 Gy to the <Anatomical_site-START> boost field <Anatomical_site-END> , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18 fractions of 2.00 Gy per fraction <RT_DOSE-START> 55 Gy <RT_DOSE-END> ) 35 Gy in 20 fractions 45 Gy total 800 cGy once per day on days - 11 to - 1 ( 10 fractions
None	week 36 Gy to areas of initial <Anatomical_site-START> bulky disease <Anatomical_site-END> to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and 14 Gy to the boost field , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18 fractions of 2.00 Gy per fraction 55 Gy ) <RT_DOSE-START> 35 Gy <RT_DOSE-END> in 20 fractions 45 Gy total 800 cGy once per day on days - 11 to - 1 ( 10 fractions
None	week 36 Gy to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of <Anatomical_site-START> regional <Anatomical_site-END> treatment and 14 Gy to the boost field , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18 fractions of 2.00 Gy per fraction 55 Gy ) <RT_DOSE-START> 35 Gy <RT_DOSE-END> in 20 fractions 45 Gy total 800 cGy once per day on days - 11 to - 1 ( 10 fractions
None	week 36 Gy to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and 14 Gy to the <Anatomical_site-START> boost field <Anatomical_site-END> , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18 fractions of 2.00 Gy per fraction 55 Gy ) <RT_DOSE-START> 35 Gy <RT_DOSE-END> in 20 fractions 45 Gy total 800 cGy once per day on days - 11 to - 1 ( 10 fractions
None	week 36 Gy to areas of initial <Anatomical_site-START> bulky disease <Anatomical_site-END> to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and 14 Gy to the boost field , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18 fractions of 2.00 Gy per fraction 55 Gy ) 35 Gy in 20 fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> total 800 cGy once per day on days - 11 to - 1 ( 10 fractions
None	week 36 Gy to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of <Anatomical_site-START> regional <Anatomical_site-END> treatment and 14 Gy to the boost field , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18 fractions of 2.00 Gy per fraction 55 Gy ) 35 Gy in 20 fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> total 800 cGy once per day on days - 11 to - 1 ( 10 fractions
None	week 36 Gy to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and 14 Gy to the <Anatomical_site-START> boost field <Anatomical_site-END> , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18 fractions of 2.00 Gy per fraction 55 Gy ) 35 Gy in 20 fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> total 800 cGy once per day on days - 11 to - 1 ( 10 fractions
None	week 36 Gy to areas of initial <Anatomical_site-START> bulky disease <Anatomical_site-END> to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and 14 Gy to the boost field , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18 fractions of 2.00 Gy per fraction 55 Gy ) 35 Gy in 20 fractions 45 Gy total <RT_DOSE-START> 800 cGy <RT_DOSE-END> once per day on days - 11 to - 1 ( 10 fractions
None	week 36 Gy to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of <Anatomical_site-START> regional <Anatomical_site-END> treatment and 14 Gy to the boost field , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18 fractions of 2.00 Gy per fraction 55 Gy ) 35 Gy in 20 fractions 45 Gy total <RT_DOSE-START> 800 cGy <RT_DOSE-END> once per day on days - 11 to - 1 ( 10 fractions
None	week 36 Gy to areas of initial bulky disease to 45 Gy in 1.5-Gy fractions to 30 Gy in 1.80-Gy fractions total of 32 fractions in 6.4 weeks : 50 Gy of regional treatment and 14 Gy to the <Anatomical_site-START> boost field <Anatomical_site-END> , for total dose of 64 Gy to 56 Gy in 28 fractions , 5 fractions per week 36 Gy in 18 fractions of 2.00 Gy per fraction 55 Gy ) 35 Gy in 20 fractions 45 Gy total <RT_DOSE-START> 800 cGy <RT_DOSE-END> once per day on days - 11 to - 1 ( 10 fractions
